Showing results (71-80 of 573) with videos related to

Sort By:
Pageof 58
Current Opinion in Infectious Diseases|August 31, 2010
Multiresistant Gram-negative infections: a global perspectiveJennifer Ho, Paul A Tambyah, David L Paterson
Genome Announcements|August 29, 2015
Draft Genome Sequences of Two IMP-4-Producing Escherichia coli Sequence Type 131 Isolates in AustraliaHanna E Sidjabat, Jennifer Robson, David L Paterson
Current Opinion in Critical Care|September 5, 2025
Management of MDR/XDR severe infections in the critically illLuca Mezzadri, Ya-Ting Chang, David L Paterson
Antimicrobial Agents and Chemotherapy|April 11, 2007
Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumanniiAnton Y Peleg, Jennifer Adams, David L Paterson
Clinical Microbiology Reviews|July 16, 2008
Acinetobacter baumannii: emergence of a successful pathogenAnton Y Peleg, Harald Seifert, David L Paterson
Microbial Drug Resistance (Larchmont, N.Y.)|February 26, 2015
Molecular Epidemiology and Mechanisms of Carbapenem Resistance of Acinetobacter spp. in Asia and OceaniaWitchuda Kamolvit, Hanna E Sidjabat, David L Paterson
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 18, 2022
An Australian perspective on antimicrobial stewardship programs and transplantationAdam G Stewart, Burcu Isler, David L Paterson
Antimicrobial Agents and Chemotherapy|November 15, 2022
Efficacy of Crushed Delayed-Release Posaconazole Tablets in Rhino-Orbito-Cerebral MucormycosisAbi Manesh, Emily Devasagayam, Kundakarla Bhanuprasad, et al.
Antimicrobial Agents and Chemotherapy|March 26, 2008
Characterization of a naturally occurring class D beta-lactamase from Achromobacter xylosoxidansYohei Doi, Laurent Poirel, David L Paterson, et al.
Current Opinion in Infectious Diseases|December 14, 2019
Current evidence for therapy of ceftriaxone-resistant Gram-negative bacteremiaDavid L Paterson, Andrew Henderson, Patrick N A Harris
Pageof 58